PF-00299804 (PF299) patient (pt)-reported outcomes (PROs) and efficacy in adenocarcinoma (adeno) and nonadeno non-small cell lung cancer (NSCLC): A phase (P) II trial in advanced NSCLC after failure of chemotherapy (CT) and erlotinib (E).
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. Campbell, K. L. Reckamp, D. R. Camidge, G. Giaccone, S. M. Gadgeel, F. R. Khuri, J. A. Engelman, L. J. Denis, J. P. O'Connell, P. A. Janne
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2282643443